| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RISPERIDONE | 1MG | TABLET | Actual shortage | 2026-01-13 | 2026-01-13 | 275933 |
| RISPERIDONE | 2MG | TABLET | Actual shortage | 2026-01-13 | 2026-01-13 | 275939 |
| RISPERIDONE | 4MG | TABLET | Actual shortage | 2026-01-13 | 2026-01-13 | 275942 |
| RISPERIDONE | 1MG | TABLET | Avoided shortage | 2024-09-09 | 2024-09-16 | 236979 |
| SANDOZ RISPERIDONE | 1MG | TABLET | Resolved | 2025-05-12 | 2025-07-03 | 257076 |
| SANDOZ RISPERIDONE | 4MG | TABLET | Actual shortage | 2025-10-06 | 2025-10-07 | 268639 |
| SANDOZ RISPERIDONE | 4.0MG | TABLET | Resolved | 2020-11-16 | 2020-12-15 | 128423 |
| SANDOZ RISPERIDONE | 3MG | TABLET | Actual shortage | 2025-10-06 | 2025-10-07 | 268632 |
| SANDOZ RISPERIDONE | 3MG | TABLET | Actual shortage | 2025-10-06 | 2025-10-07 | 268629 |
| SANDOZ RISPERIDONE | 3MG | TABLET | Resolved | 2023-06-19 | 2023-07-18 | 195422 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
| MYLAN-RISPERIDONE | 4.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16169 |
| MYLAN-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16166 |
| MYLAN-RISPERIDONE | 2.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16163 |
| MYLAN-RISPERIDONE | 0.25MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16154 |
| MYLAN-RISPERIDONE | 0.50MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16157 |
| MYLAN-RISPERIDONE | 1.0MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16160 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |